Literature DB >> 19794278

Acute acalculous cholecystitis revealing hepatitis A virus infection in children.

Mounir Arroud, Sara Benmiloud, Bouchra Oudghiri, My Abderrahmane Afifi, Moustapha Hida, Youssef Bouabdallah.   

Abstract

Entities:  

Mesh:

Year:  2009        PMID: 19794278      PMCID: PMC2981849          DOI: 10.4103/1319-3767.56098

Source DB:  PubMed          Journal:  Saudi J Gastroenterol        ISSN: 1319-3767            Impact factor:   2.485


× No keyword cloud information.
Sir, Acute hepatitis A virus (HAV) infection is frequently encountered in developing countries, especially in children. The occurrence of acute acalculous cholecystitis (AAC) during HAV infection is uncommon and it has been exceptionally described in the literature.[12] An 11-year old boy, with an unremarkable medical history, was admitted to the pediatric emergency department with a 4-day history of fever, asthenia, vomiting and abdominal pain. At presentation, the patient had myalgia, jaundice associated with dark urine and pale stool. Physical examination showed body temperature of 38.8°C, scleral and cutaneous icterus and a painful hepatomegaly without associated splenomegaly. Laboratory studies revealed the following: Hemoglobin, 11.4 mg/dL; white blood cell, 6300/mm3; alanine aminotransferase, 1918 U/L (Normal: 7-40 U/L); aspartate aminotransferase, 2953 U/L (Normal: 7-40 U/L); total serum bilirubin, 48 mg/L; with a direct fraction of 27 mg/L, alkaline phosphates 573 U/L (Normal: 38-155 U/L); gamma-glutamyl-transpeptidase, 214 U/L (15-60 U/L); albumin, 3.3 g/dl; prothrombin rate at 62%; C-reactive protein, 66 mg/L (0-5 mg/L). Abdomen ultrasonography showed a marked thickness of the gallbladder wall evaluated at 11 mm (Normal: ≤2 mm), with a pericholecystic fluid collection and heterogeneous hydrops with no calculi or sludge. The intrahepatic and extrahepatic biliary tracts were normal. Sepsis was suspected and intravenous antibiotics associating clavulanic acid combined with amoxicillin and gentamicin were administered. The serologic tests showed specific IgM anti-HAV. Viral hepatitis B and C and typhoid diseases were excluded serologically. Bacteriological and parasitological examinations of stools also yielded negative results. During follow-up, the child remained febrile for three days. At the fifth day, the jaundice and abdominal tenderness regressed. Four days later, the patient was discharged in a stable condition. After one month, abdominal ultrasonography was normal and a significant improvement was also seen in biochemical test results. HAV infection symbolizes an asymptomatic and benign disease. Cholestasis, relapse and fulminant hepatitis are the three major complications.[3] Pathophysiology of the gallbladder wall thickness remains unclear. Hypoalbuminemia, local extension of the hepatic inflammatory process and direct lesions of the biliary epithelium caused by the virus are the main suggested hypotheses.[4] Clinical symptoms include fever, jaundice, pain and guarding in the right hypochondrium. Homogeneous or stratified gallbladder wall thickness, greater than 10 mm, noted in ultrasonography examination without any calculous or sludge, confirm the diagnosis of acute acalculous cholecystitis. The diagnosis of AAC due to HAV infection can be established in the presence of important cytolysis with positive specific IgM anti-HAV. Other possible etiologies of AAC such as salmonellosis, parasitosis of the digestive tract, Kawasaki syndrome and sepsis must be excluded.[2] AAC as a result of HAV infection is transient and gradually disappears when viremia becomes low. Concurrently, gallbladder wall thickness returns to normal size within a few days. Therefore, patients do not require surgical intervention. The occurrence of AAC during HAV infection is exceptional. It usually manifests as abdominal pain associated with fever and icterus. This diagnosis should be kept in mind by paediatricians and gastroenterologists to avoid unnecessary invasive procedures.
  4 in total

1.  [Acute hepatitis, a virus revealed by a calculous cholecystisis].

Authors:  Bertrand Tissot
Journal:  Gastroenterol Clin Biol       Date:  2004-02

2.  Hepatitis A: a rare cause of acalculous cholecystitis in children.

Authors:  O Bouyahia; I Khelifi; F Bouafif; S Mazigh Mrad; L Gharsallah; S Boukthir; A Sammoud El Gharbi
Journal:  Med Mal Infect       Date:  2007-12-21       Impact factor: 2.152

Review 3.  [Extrahepatic manifestations of hepatitis A virus infection].

Authors:  M Y Maïga; F Oberti; P Calès
Journal:  Gastroenterol Clin Biol       Date:  1996

4.  Gallbladder and pancreatic involvement in hepatitis A.

Authors:  A Klar; D Branski; M Nadjari; M Y Akerman; D Shoseyov; H Hurvitz
Journal:  J Clin Gastroenterol       Date:  1998-09       Impact factor: 3.062

  4 in total
  6 in total

1.  Hepatitis a with pleural effusion, ascites and acalculous cholecystitis.

Authors:  Ela Erdem; Nafiye Urgancı; Yasemin Ceylan; Nursu Kara; Gul Ozcelik; Seda Geylani Gulec
Journal:  Iran J Pediatr       Date:  2010-12       Impact factor: 0.364

2.  Acute Acalculous Cholecystitis due to Viral Hepatitis A.

Authors:  Safak Kaya; Ahmet Emre Eskazan; Nurettin Ay; Birol Baysal; Mehmet Veysi Bahadir; Arzu Onur; Recai Duymus
Journal:  Case Rep Infect Dis       Date:  2013-09-10

3.  Gallbladder hydrops due to viral hepatitis a infection: a case report.

Authors:  Mitra Aldaghi; Mahmoud Haghighat; Seyed Mohsen Dehghani
Journal:  Jundishapur J Microbiol       Date:  2014-12-10       Impact factor: 0.747

Review 4.  Acalculous Acute Cholecystitis in Previously Healthy Children: General Overview and Analysis of Pediatric Infectious Cases.

Authors:  Dimitri Poddighe; Matteo Tresoldi; Amelia Licari; Gian Luigi Marseglia
Journal:  Int J Hepatol       Date:  2015-11-11

5.  A Case Report of Acute Abdominal Pain From a Rare Infectious Etiology.

Authors:  Ramya Deepthi Billa; Eric McGrath
Journal:  Glob Pediatr Health       Date:  2018-07-10

Review 6.  Acute acalculous cholecystitis in children.

Authors:  Dimitri Poddighe; Vitaliy Sazonov
Journal:  World J Gastroenterol       Date:  2018-11-21       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.